$GLBE Balance Sheet | Understand Stock

$GLBE

$41.24 -$0.12 (0.29%) Pre-market

$GLBE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
Assets
Current assets:
Cash and cash equivalents
Short-term deposits
Accounts receivable, net (net of allowance for credit losses of $1,110 and $522 as of December 31, 2024 and 2025, respectively)
Prepaid expenses and other current assets
Marketable securities
Funds receivable, including cash in banks
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Long-term deposits
Deferred contract acquisition and fulfillment costs, noncurrent
Long-term investments and other long-term assets
Deferred tax assets
Other assets, noncurrent
Long-term investment
Commercial agreement asset
Goodwill and other intangible assets
Goodwill
Intangible assets, net
Total long-term assets
Total assets

Liabilities, and Shareholders’ Equity
Current liabilities:
Accounts payable (including related party payables of $51,226 and $59,574 as of December 31, 2024 and 2025, respectively)
Accrued expenses and other current liabilities (including related party payables of $10,279 and $14,843 as of December 31, 2024 and 2025, respectively)
Funds payable to customers
Short-term operating lease liabilities
Total current liabilities
Long-term liabilities:
Deferred tax liabilities, net
Warrants liabilities to preferred shares
Long-term operating lease liabilities
Other long-term liabilities
Total liabilities
Convertible preferred shares, with no par value, 162,875 and no shares authorized as of December 31, 2020 and 2021, respectively; 162,101 and no issued and outstanding as of December 31, 2020 and 2021, respectively; aggregate liquidation preference of $113,276 and $0 as of December 31, 2020 and 2021, respectively;
Shareholders’ equity:
Ordinary Shares, with no par value, 300,000,000 shares authorized as of December 31, 2024 and 2025, respectively; 169,131,268 and 169,049,616 shares issued and outstanding as of December 31, 2024 and 2025, respectively;
Additional paid-in capital
Accumulated comprehensive income
Accumulated deficit
Total shareholders’ equity
Total liabilities, and shareholders’ equity

Comments